Vivani Medical, Inc. (VANI) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Vivani Medical, Inc. (VANI) closed at USD 1.16 on 2026-10-14, a change of -30.5 % over the past year, with a market capitalization of USD 103.73M.

Vivani Medical, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Vivani Medical, Inc. key figures

Previous close

USD 1.16 (2026-10-14)

1-year change

-30.5 %

Market cap

USD 103.73M

Enterprise value

USD 101.7M

P/E ratio (trailing)

-3.19

P/E ratio (forward)

-3.29

EPS (trailing)

-0.36

EPS (forward)

-0.35

PEG ratio

n/a

Price to book

5.42

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.24

Employees

42

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Vivani Medical, Inc.

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Vivani Medical, Inc. and compare it with other stocks.